Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Neurobiol Dis. 2010 Oct 23;41(2):436–444. doi: 10.1016/j.nbd.2010.10.015

Figure 5.

Figure 5

Body weight and survival are not affected by ampakine treatment. (A) The body weight of vehicle (Veh)-treated R6/2 mice significantly differed from WTs starting at 10 weeks of age (n=12 and 13, respectively; p=0.01, Student’s t-test) and progressively declined throughout their lifespan. CX929 treatment did not affect body weight in R6/2 or WT mice (n=15 and 11, respectively). (B) The lifespan of R6/2 mice treated with CX929 did not significantly differ from those given vehicle (Cohort 3). See text for details of statistical comparisons.